Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 434INDUSTRY 102OTHER_GOV 19NIH 14NETWORK 7UNKNOWN 6FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Prostatic Neoplasms 53Colorectal Neoplasms 42Neoplasms 37Lung Neoplasms 22Breast Neoplasms 15Colonic Neoplasms 14Colonic Polyps 13Rare Diseases 9Carcinoma, Non-Small-Cell Lung 9Carcinoma, Hepatocellular 9Ovarian Neoplasms 7Adenoma 7Pulmonary Disease, Chronic Obstructive 6Neoplasm Metastasis 6Heart Failure 6Head and Neck Neoplasms 6Rectal Neoplasms 5Motor Activity 5Liver Neoplasms 5Fibrosis 5Carcinoma, Squamous Cell 5Barrett Esophagus 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Neoplasms by Site 4Mental Disorders 4Lymphoma 4Lung Diseases 4Leukemia 4Esophageal Neoplasms 4

Interventions

Itraconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
FED × Esophageal Squamous Cell Carcinoma × Clear all
NCT05563766 2025-11-05

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

VA Office of Research and Development

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT04018872 2021-11-04

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Dallas VA Medical Center

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡